22041-23-2

Usage

Uses

Used in Flavor and Fragrance Industry:
ETHYL 4-(DIMETHYLAMINO)BUTANOATE is used as a flavoring agent for its fruity odor, enhancing the taste and aroma of various food and cosmetic products.
Used in Pharmaceutical Industry:
ETHYL 4-(DIMETHYLAMINO)BUTANOATE is used in the synthesis of pharmaceuticals, serving as an intermediate in organic synthesis to create various medicinal compounds.
Used in Cosmetic Industry:
ETHYL 4-(DIMETHYLAMINO)BUTANOATE is used as a flavoring agent in cosmetic products, contributing to their pleasant scent and enhancing consumer experience.
Used in Topical Anesthetic Products:
ETHYL 4-(DIMETHYLAMINO)BUTANOATE is known for its mild anesthetic effects and is used in some topical anesthetic products to provide temporary pain relief.
It is important to handle this chemical with caution and follow proper safety protocols due to its potential health hazards.

InChI:InChI=1/C8H17NO2/c1-4-11-8(10)6-5-7-9(2)3/h4-7H2,1-3H3

Upstream product

• 64-17-5 ethanol 
• 693-11-8 4-dimethylamino-butyric acid 
• 5429-29-8 1,3-diethyl 2-[2-(dimethylamino)ethyl]propanedioate 
• 2969-81-5 Ethyl 4-bromobutyrate 
• 124-40-3 dimethyl amine 

Downstream Products

• 13330-96-6 4-dimethylamino-1-butanol 
• 5471-47-6 γ-Dimethylaminobutyrohydrazid 
• 1580507-02-3 N-benzyl-4-ethoxy-N,N-dimethyl-4-oxobutan-1-aminium bromide 
• 1580507-20-5 4-(benzyldimethylammonio)butanoate 
• 69954-66-1 4-(dimethylamino)butyric acid hydrochloride 
• 1357620-10-0 3-(4-(dimethylamino)butanamido)benzoic acid 
• 751479-06-8 4-(4-(dimethylamino)butanamido)benzoic acid 
• 1357620-07-5 benzyl 3-(4-(dimethylamino)butanamido)benzoate 
• 1357620-05-3 benzyl 4-(4-(dimethylamino)butanamido)benzoate 

Relevant academic research and scientific papers

Formulation optimization of an ephrin A2 targeted immunoliposome encapsulating reversibly modified taxane prodrugs

Ephrin A2 targeted immunoliposomes incorporating pH-sensitive taxane prodrugs were developed for sustained delivery of active drug to solid tumors. Here we describe the systematic formulation development and characterization of these immunoliposomes. We s

AMPHOTERIC BETAINE COMPOUNDS

Disclosed are a variety of amphoteric compounds containing a quaternary nitrogen group, a covalently bound counterion, and an ester or amide group. These amphoteric compounds can be advantageously prepared via a chemoenzymatic green process, and exhibit good surfactant properties.

Targeting carnitine biosynthesis: Discovery of new inhibitors against γ-butyrobetaine hydroxylase

γ-Butyrobetaine hydroxylase (BBOX) catalyzes the conversion of gamma butyrobetaine (GBB) to l-carnitine, which is involved in the generation of metabolic energy from long-chain fatty acids. BBOX inhibitor 3-(1,1,1-trimethylhydrazin-1-ium-2-yl)propanoate (

Synthesis of benzoic acids and polybenzamides containing tertiary alkylamino functionality

The high-yielding and easily scalable synthesis of a number of benzoic acids bearing a tertiary alkylamino functionality has been achieved. The flexible synthesis began from readily available aminobenzoic acids or terephthaloyl chloride and requires almost no chromatography. Coupling of the synthesised amino acids to a range of substituted anilines was achieved when utilizing a specific combination of DIC, HOBt and DMAP.

4-[(HALOALKYL)(DIMETHYL)AMMONIO]BUTANOATES AND USE THEREOF IN THE TREATMENT OF CARDIOVASCULAR DISEASE

4-[(Haloalkyl)(dimethyl)ammonio]butanoates of formula (I) wherein Hal is Cl or F, n=1 or 2, method for preparing thereof and use thereof for treating cardiovascular disease.